When assessing the diversification of the collateral, should re-invested cash collateral be aggregated with non-cash collateral?

Can cash collateral received by UCITS in the context of EPM techniques or OTC financial derivative transactions be used by UCITS for clearing obligations under EMIR?

Are government bonds exempt from the provisions laid down in paragraphs 43(a) and paragraphs 43 (e) of the guidelines?

Do the ESMA guidelines require that counterparty risk exposures be aggregated across both financial derivative instruments and efficient portfolio management techniques?

In the case of government bonds, can the 20% limit be deemed to apply to each different issue of bonds of the same issuer?